scholarly article | Q13442814 |
P2093 | author name string | Shunichi Homma | |
Ira J Goldberg | |||
Hye-Lim Noh | |||
Yunying Hu | |||
Tae-Sik Park | |||
Kazue Okajima | |||
Andrew J Nichols | |||
Thomas DiCioccio | |||
P2860 | cites work | Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice | Q24530027 |
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk | Q28220058 | ||
Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity | Q31879944 | ||
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice | Q32085363 | ||
Reaction of monosaccharides with proteins: possible evolutionary significance | Q33960984 | ||
A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. | Q34330003 | ||
Mouse models of mitochondrial dysfunction and heart failure | Q35995691 | ||
Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? | Q36001352 | ||
Glucose and diabetic vascular disease. | Q36379991 | ||
Diabetic vascular disease: an experimental objective | Q36500921 | ||
Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? | Q36775094 | ||
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
Cloning and characterization of Leishmania mexicana fructose-1,6-bisphosphate aldolase | Q38967630 | ||
Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition | Q40222083 | ||
Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway | Q40729629 | ||
Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-ric | Q41664275 | ||
Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart | Q42521720 | ||
Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach | Q43572799 | ||
Aldose reductase activation is a key component of myocardial response to ischemia | Q43843299 | ||
Increased fructose concentrations in blood and urine in patients with diabetes | Q43869416 | ||
Regulation of rat intestinal GLUT2 mRNA abundance by luminal and systemic factors | Q44466325 | ||
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice | Q44474816 | ||
Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). | Q44542257 | ||
Urinary sorbitol measurement and the effect of an aldose reductase inhibitor on its concentration in the diabetic state | Q44635139 | ||
Central role for aldose reductase pathway in myocardial ischemic injury | Q45000419 | ||
Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice. | Q45241682 | ||
Trehalose and 6-aminohexanoic acid stabilize and renature glucose-6-phosphate dehydrogenase inactivated by glycation and by guanidinium hydrochloride | Q46447820 | ||
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. | Q46460053 | ||
Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction | Q57396503 | ||
Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes | Q68223509 | ||
Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the Maillard reaction initiated by glucose | Q69330169 | ||
Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients | Q71548944 | ||
Molecular Chaperones Protect Against Glycation-Induced Inactivation of Glucose-6-Phosphate Dehydrogenase | Q71940499 | ||
Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA | Q72258241 | ||
An enzymatic fluorometric assay for fructose | Q73734924 | ||
Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy | Q79257400 | ||
Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells | Q79441361 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 496-503 | |
P577 | publication date | 2008-10-30 | |
P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
P1476 | title | Regulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat | |
P478 | volume | 328 |
Q37751655 | Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. |
Q34042977 | Fructose modulates cardiomyocyte excitation-contraction coupling and Ca²⁺ handling in vitro |
Q42078154 | High fructose diet suppresses exercise-induced increase in AQP7 expression in the in vivo rat heart |
Q35753067 | Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice |
Q88643832 | Intestinal Absorption of Fructose |
Q34549870 | Protective effects of astragaloside IV on db/db mice with diabetic retinopathy |
Search more.